KINIKSA PHARMACEUTICALS
Kiniksa Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with a significant unmet medical need. It has a pipeline of product candidates across various stages of development, currently focused on autoinflammatory and autoimmune conditions. It has three clinical-stage product candidates, one of which is anticipated to commence a Phase 3 clinical tr... ial in 2018. They follow a disciplined and methodical approach to selectively identify and acquire product candidates with strong biologic rationales or validated mechanisms of action. The company's portfolio of product candidates offers multiple development opportunities. By modulating different parts of the innate and adaptive immune system, these product candidates together have the potential to provide a variety of mechanisms to address multiple devastating diseases.
KINIKSA PHARMACEUTICALS
Industry:
Biopharma Biotechnology Medical
Founded:
2015-01-01
Address:
Hamilton, Hamilton, Bermuda
Country:
Bermuda
Website Url:
http://www.kiniksa.com
Total Employee:
11+
Status:
Active
Contact:
(781) 431-9100
Email Addresses:
[email protected]
Total Funding:
400 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Tag Manager Content Delivery Network Domain Not Resolving Nginx Euro Microsoft Exchange Online
Similar Organizations
Arrakis Therapeutics
Arrakis Therapeutics is a biopharmaceutical developing drugs for neurological disorders and other diseases.
AxisPharm
AxisPharm specializes in ADC drug development, bioconjugation, mass spectrometry, and structure elucidation.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Sirnaomics
Sirnaomics is a biopharmaceutical company developing therapeutics for critical human diseases by using RNA interference technology.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Employees Featured
Founder
Stock Details
Investors List
Fidelity
Fidelity investment in Series C - Kiniksa Pharmaceuticals
Cormorant Asset Management
Cormorant Asset Management investment in Series C - Kiniksa Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Series C - Kiniksa Pharmaceuticals
Deerfield
Deerfield investment in Series C - Kiniksa Pharmaceuticals
Baker Brothers Advisors LLC
Baker Brothers Advisors LLC investment in Series C - Kiniksa Pharmaceuticals
Venrock Healthcare Capital Partners
Venrock Healthcare Capital Partners investment in Series C - Kiniksa Pharmaceuticals
ArrowMark Partners
ArrowMark Partners investment in Series C - Kiniksa Pharmaceuticals
Baker Brothers Advisors LLC
Baker Brothers Advisors LLC investment in Series B - Kiniksa Pharmaceuticals
Baker Brothers Advisors LLC
Baker Brothers Advisors LLC investment in Series A - Kiniksa Pharmaceuticals
Official Site Inspections
http://www.kiniksa.com
- Host name: 151.101.1.193
- IP address: 151.101.1.193
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Kiniksa Pharmaceuticals" on Search Engine
Kiniksa Pharmaceuticals | LinkedIn
Kiniksa is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant...See details»
Kiniksa Pharmaceuticals - Crunchbase Company Profile & Funding
Phone Number (781) 431-9100. Kiniksa Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and …See details»
Kiniksa Pharmaceuticals Announces Global License Agreement …
HAMILTON, Bermuda, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company with a portfolio of assets …See details»
Pipeline of Product Candidates | Kiniksa Pharmaceuticals
Learn about Kiniksa’s pipeline of product candidates for debilitating and devastating diseases.See details»
Kiniksa Announces Results from Phase 3 Trial of - GlobeNewswire
HAMILTON, Bermuda, Dec. 28, 2021 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (“Kiniksa”), a biopharmaceutical company with a portfolio of …See details»
Kiniksa Pharmaceuticals | KNSA Stock Price, Company Overview …
Kiniksa Pharmaceuticals Ltd. is a biopharmaceutical company, which engages in discovering, acquiring, developing, and commercializing therapeutic medicines for …See details»
Kiniksa Pharmaceuticals Announces Development Indication for …
HAMILTON, Bermuda, April 02, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a commercial-stage biopharmaceutical company with a …See details»
FDA-Approved Medicines | Kiniksa Pharmaceuticals
Our Medicines. VIEW FULL PRESCRIBING INFORMATION (PDF) VISIT ARCALYST.COM. VIEW RHAPSODY LONG TERM EXTENSION DATA PRESENTED …See details»
Kiniksa Pharmaceuticals Announces Development Indication for …
HAMILTON, Bermuda, April 02, 2024 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a commercial-stage biopharmaceutical company with a …See details»
SEC Filing | Kiniksa Pharmaceuticals
HAMILTON, BERMUDA – January 13, 2020 – Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company focused on discovering, acquiring, …See details»
Kiniksa Pharmaceuticals to Report Fourth Quarter and Full-Year …
Feb 21, 2024 Kiniksa is a commercial-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for …See details»
Kiniksa Pharmaceuticals Announces Global License Agreement
HAMILTON, Bermuda, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals, Ltd. (Nasdaq: KNSA) (Kiniksa), a biopharmaceutical company with a portfolio of assets …See details»
SEC Filing | Kiniksa Pharmaceuticals
Kiniksa Pharmaceuticals, Ltd. (the “Company”) is a biopharmaceutical company focused on discovering, acquiring, developing and commercializing therapeutic medicines for …See details»
Kiniksa Pharmaceuticals - Funding, Financials, Valuation
Kiniksa Pharmaceuticals is registered under the ticker NASDAQ:KNSA . Their stock opened with $18.00 in its May 23, 2018 IPO. Kiniksa Pharmaceuticals is funded by 7 …See details»
Kiniksa Pharmaceuticals - Contacts, Employees, Board …
Kiniksa Pharmaceuticals is developing therapies for inflammatory and autoimmune conditions.See details»
Abiprubart by Kiniksa Pharmaceuticals for Sicca Syndrome …
3 days ago Kiniksa Pharmaceuticals (Kiniksa) is a biopharmaceutical company that discovers, acquires, develops and commercializes medicines to treat autoinflammatory …See details»
KINIKSA PHARMACEUTICALS LTD
March 14, 2024 . 1 . US-DOCS\138625993.2 142184036_2 . K. INIKSA . P. HARMACEUTICALS, L. TD. C. ORPORATE GOVERNANCE GUIDELINES. The Board …See details»
Jump Financial LLC Makes New $951,000 Investment in Kiniksa ...
1 day ago Jump Financial LLC bought a new position in Kiniksa Pharmaceuticals, Ltd. ( NASDAQ:KNSA - Free Report) in the 4th quarter, according to the company in its most …See details»
Kiniksa Pharmaceuticals hiring Associate Director, Corporate ...
Just now. Be among the first 25 applicants. See who Kiniksa Pharmaceuticals has hired for this role. Apply. Save job. Save this job with your existing LinkedIn profile, or create a …See details»
Kiniksa Pharmaceuticals (KNSA) Earnings Date and Reports …
3 days ago KNSA Earnings Date and Information. Kiniksa Pharmaceuticals last announced its earnings data on April 23rd, 2024. The reported ($0.25) earnings per …See details»